Variant report
Variant | esv21047 |
---|---|
Chromosome Location | chr2:31403351-31411711 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs60854003 | chr2:31403360-31403361 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs566347083 | chr2:31403362-31403363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182386297 | chr2:31403370-31403371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548762420 | chr2:31403395-31403396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568516155 | chr2:31403406-31403407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536357764 | chr2:31403474-31403475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78705783 | chr2:31403520-31403521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377102621 | chr2:31403522-31403523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115428238 | chr2:31403539-31403540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149760139 | chr2:31403573-31403574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558454988 | chr2:31403603-31403604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572295701 | chr2:31403605-31403606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540915300 | chr2:31403628-31403629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116356768 | chr2:31403654-31403655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574506286 | chr2:31403716-31403717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370514331 | chr2:31403748-31403749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543956945 | chr2:31403848-31403849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372449814 | chr2:31403857-31403858 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199964386 | chr2:31403862-31403863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201159308 | chr2:31403875-31403876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76939962 | chr2:31403879-31403880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377551095 | chr2:31403915-31403916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73921565 | chr2:31403920-31403921 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs548562879 | chr2:31403944-31403945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2028678 | chr2:31403947-31403948 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs145715824 | chr2:31403961-31403962 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2028677 | chr2:31404001-31404002 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs374463082 | chr2:31404020-31404021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2028676 | chr2:31404031-31404032 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs368345214 | chr2:31404035-31404036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545138483 | chr2:31404043-31404044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2028675 | chr2:31404064-31404065 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs116577373 | chr2:31404082-31404083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192506296 | chr2:31404089-31404090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554541112 | chr2:31404108-31404109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532334999 | chr2:31404122-31404123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73921566 | chr2:31404147-31404148 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs563813858 | chr2:31404191-31404192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372310273 | chr2:31404205-31404206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184807777 | chr2:31404209-31404210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561586060 | chr2:31404215-31404216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs4337516 | chr2:31404254-31404255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs7569173 | chr2:31404264-31404265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538044256 | chr2:31404265-31404266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200190396 | chr2:31404268-31404269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs367769826 | chr2:31404295-31404296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187305901 | chr2:31404297-31404298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571907957 | chr2:31404301-31404302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370290944 | chr2:31404309-31404310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192019086 | chr2:31404312-31404313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:31388400-31407000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr2:31391200-31418600 | Weak transcription | Gastric | stomach |
3 | chr2:31394800-31419600 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr2:31395200-31416600 | Weak transcription | Primary B cells from peripheral blood | blood |
5 | chr2:31395800-31415000 | Weak transcription | Esophagus | oesophagus |
6 | chr2:31403800-31404000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr2:31404000-31415800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr2:31407000-31407600 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr2:31407600-31412800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr2:31410400-31414600 | Weak transcription | Primary hematopoietic stem cells | blood |
11 | chr2:31410800-31420400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr2:31411000-31421800 | Weak transcription | Primary T cells from cord blood | blood |
13 | chr2:31411000-31427400 | Weak transcription | Fetal Brain Female | brain |
14 | chr2:31411200-31436800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |